These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8540445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
    Raja SG, Danton MD, MacArthur KJ, Pollock JC.
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.
    Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B.
    Am J Cardiol; 1996 Mar 01; 77(7):532-5. PubMed ID: 8629600
    [Abstract] [Full Text] [Related]

  • 9. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):98-104. PubMed ID: 19089967
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide-related compounds in patients with congenital heart defects and pulmonary hypertension.
    Kotake F, Kobayashi J, Sonoda M, Komoda T.
    Pediatr Int; 2000 Jun 01; 42(3):249-54. PubMed ID: 10881580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease.
    Miller OI, Celermajer DS, Deanfield JE, Macrae DJ.
    J Thorac Cardiovasc Surg; 1994 Sep 01; 108(3):487-94. PubMed ID: 8078341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.
    Kiettisanpipop P, Lertsapcharorn P, Chotivittayatarakorn P, Poovorawan Y.
    J Med Assoc Thai; 2007 Oct 01; 90(10):2053-7. PubMed ID: 18041423
    [Abstract] [Full Text] [Related]

  • 18. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease.
    Alvarez Kindelan A, Pérez Navero JL, Ibarra de la Rosa I, Concha Ruiz M, Montilla López P, Romanos Lezcano A.
    Crit Care Med; 1994 Nov 01; 22(11):1754-61. PubMed ID: 7956278
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F, Uese K, Hashimoto I, Hamamichi Y, Tsubata S, Fukahara K, Murakami A, Miyawaki T.
    J Cardiol; 1997 Apr 01; 29(4):217-24. PubMed ID: 9127838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.